Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Clinical trial NCT01626378 · COMPLETED
Trial details
- NCT number
- NCT01626378
- Sponsor
- TauRx Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.